BYV RNA isolated from purified virus by phenol extraction was analysed on 0.8~ agarose gels after denaturation in the presence of glyoxal (McMaster & Carmichael, 1977) . RNAs from brome mosaic virus [RNAs 1, 2, 3 and 4 of 3200, 2900, 2100 and 900 nucleotides, respectively (Ahlquist et al., 1984) ], tobacco mosaic virus [type strain, 6400 nucleotides (Goelet et al., 1982) ] and Sendai virus [15400 nucleotides (Shioda et al., 1986) ] were used as internal size markers. Sendai virus RNA was kindly provided by Dr N. V. Kaverin (Ivanovsky Institute of Virology, Moscow, U.S.S.R.). Denatured BYV RNA gave one major band on agarose gel corresponding to a length of approx. 14500 nucleotides (data not shown). This correlates well with the previous estimations of BYV RNA size (Bar Joseph & Hull, 1974; .
Translation of BYV RNA was tested in vitro in Krebs-2 cell extract prepared and used as in previously published procedures (Svitkin & Agol, 1978; Svitkin et al., 1981) . All incubations were at 30 °C in a standard reaction volume of 25 ~tl, containing 15 ~tl of K rebs-2 $30 fraction, 40 to 80 txg/ml RNA, 18 mM-Tris-HC1 pH 7-6, 1-5 mM-ATP, 0-1 mM-GTP, 10 mM-creatine phosphate, 80 ~tg/ml creatine phosphokinase, 40 ~M each of the 19 unlabelled amino acids and 20 ~tCi L-[ 3 SS]methionine (Amersham; 1100 Ci/mmol). The optimal concentrations of salts were 90mM-KC1, 75mM-potassium acetate, 2.1 mM-MgCI2 and 0.1 mM-spermine. Translation products were analysed in 8 to 20~ polyacrylamide gradient slab gels according to Laemmli (1970) and visualized by autoradiography. Immunoprecipitation of 35S-labelled products was done essentially as described by Robinson et al. (1983) .
BYV RNA translation in vitro resulted in two-to fourfold stimulation of L-[35S]methionine incorporation in the TCA-insoluble fraction. The messenger activity of BYV RNA was thus at least 10 times less than that of potato virus X (PVX) and tobacco mosaic virus (TMV) RNAs taken as controls.
To test translation of the whole spectrum of probable BYV-specific messengers present in the purified virus preparation, total virion RNA was fractionated in 5 to 20~ sucrose density gradients made with 10 mM-Tris-HC1, pH 7.4, 1 mM-EDTA and 0.2~ SDS ( Fig. la) . After centrifugation at 39000 r.p.m, for 4.5 h in a Beckman SW41 rotor at 16 °C, RNA was recovered from 0-35 ml fractions by ethanol precipitation. Agarose gel analysis of glyoxal-denatured RNA from gradient fractions 22 to 25 revealed only genome-size RNA (not shown). Translation of these BYV RNA fractions yielded a large major product of Mr 250000 (p250), as well as some lighter polypeptides ( Fig. 1 b) . On the other hand, the lighter RNA fractions directed no evident virus-specific translation (Fig. lb) . Time course experiments showed that p250 appeared after 120 min of incubation, with no significant changes in the ratio of p250 to ligher products observed between 150 min and 240 min of incubation (data not shown). Taken together, these results clearly indicated that p250 synthesis in vitro was directed by the full-length BYV RNA. The lighter products could arise from premature termination of p250 translation.
The cap analogue mVGpp (Sigma), added at a concentration of 1 to 2 mM strongly inhibited the stimulation of [35S]methionine incorporation into the TCA-insoluble fraction in the BYV RNA-programmed Krebs-2 system. PAGE analysis of labelled products revealed that mTGpp blocked the synthesis of all the BYV-specific polypeptides in vitro (Fig. 2) . In controls, the cap analogue completely inhibited translation of PVX RNA bearing a 5' cap structure (Sonenberg et al., 1978) and had no effect on translation of TMV intermediate length subgenomic RNA, Iz RNA which is not capped (Joshi et al., 1983) (Fig. 2) . These data could indicate that the BYV genome is capped.
When SDS-dissociated BYV was analysed in 8 to 20~ gradient slab gels to characterize its coat protein, only one zone was visualized which corresponded to a polypeptide of Mr 24000 (data not shown). This result is in good agreement with the previous estimations of Hull (1974) and . None of the BYV RNA in vitro translation products coincided with the coat protein in electrophoretic mobility (Fig. 1, 2) . Moreover, no in vitro products were found to be immunoprecipitable with the anti-BYV ~-globulins (data not shown).
The use of rabbit reticulocyte lysate (Pelham & Jackson, 1976) in some experiments gave no I I I I I I I I I I I I III I I I I I I I I I II I I I I   /   11 II III  II IIII  IIIII  I II I I II III  I I advantage in total [3SS]methionine incorporation. The molecular weight of the products synthesized in this translation system did not exceed 230000 (data not shown). This was the reason for the use of the Krebs-2 cell-free system throughout this work. Affinity chromatography on oligo(dT)-cellulose columns was conducted as described previously (Agranovsky et al., 1983) . R N A from PVX which contained a 3'-terminal . The volume of translation mixture loaded on the gel was 8 and 2.5 ~tl for lanes 1 to 4 and 5 to 9, respectively. The Mr markers were the same as in Fig. 1 (b) .
polyadenylate tract (Morozov et al., 1981) and TMV R N A which had no poly(A) (Goelet et al., 1982) served as controls. Non-specific adsorption (i.e. the percentage of bound and then eluted u.v.-absorbing material) was about 2 ~ for TMV RNA. Under the same conditions, the binding of a pure polyadenylic acid preparation (Sigma) and PVX R N A amounted to 100~ and 90~, respectively. Upon chromatography of virion BYV RNA, about 98 ~ of the material was not bound to immobilized oligo(dT). The experiment was repeated three times with different BYV R N A preparations. This result suggests the absence of extensive poly(A) sequences in the BYV genome. The fact that the addition of oligo(dT) primer did not significantly stimulate the efficiency of the reverse transcription of BYV R N A in vitro was also in line with this conclusion (result not shown). Our preliminary results showed that the 3' terminus of the BYV genome is represented by a heteropolymeric sequence ending in cytosine.
To test for the presence of a covalently bound protein in the BYV genome, an attempt was made to label the virus R N A with 125I-labelled Bolton & Hunter reagent (Amersham; 2000 Ci/mmol) using the protocol of Rothberg et al. (1978) . R N A from encephalomyocarditis virus (EMC) having VPg (Hruby & Roberts, 1978) was labelled in a parallel sample. After labelling, 10 ~tl aliquots were treated with RNase T 1 (Sankyo; 0.3 units per 12 ~tg RNA), at 37 °C for 1 h. RNase-treated and non-treated samples were analysed on agarose mini-gels. The gels were stained with ethidium bromide and viewed in a u.v. transilluminator, followed by autoradiography to visualize ~ zSI-labelled products. After the reaction, the incorporated label in control samples comlgrated with the full-length EMC virus R N A in 1 ~ agarose. Treatment with RNase resulted in degradation of the virus RNA, and the label thus disappeared from the respective gel tracks. No a zSI-labelled material that co-electrophoresed with virus R N A was found in samples containing BYV R N A (data not shown). These results strongly suggest that the BYV genome is devoid of a covalently linked protein.
Thus, the genome of BYV is represented by a messenger-sense RNA which is not polyadenylated but is probably capped. It has been reported recently that the virion RNA of CLSV, a member of the subgroup A of closteroviruses (Bar Joseph & Murant, 1982) , contains a poly(A) sequence (Yoshikawa & Takahashi, 1988) . Hence representatives of subgroups A and B display sharp differences not only in the mode of transmission and genome length, but also in some peculiarities of their RNA terminal structure.
The largest BYV-specific protein detected in vitro, p250, accounts for about one-half of the coding capacity of the genome (apparently, representing its Y-terminal region). The mode of expression of the remainder of the genome, including that of the coat protein gene, is presently under study.
